# A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Study · id `cardio:ct-nct01251146` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01251146](<https://clinicaltrials.gov/study/NCT01251146>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01251146

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

## Technical summary

Registry record NCT01251146. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2012-11-30.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 177 participants (enrolled count; ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Primary completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Results first posted: 2012-11-30 (ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01251146, source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01251146-2017-03-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
- Condition: Hypertension
- Intervention (Drug): Bisoprolol
- Intervention (Drug): Atenolol
- Lead sponsor: Merck KGaA, Darmstadt, Germany
- Lead sponsor class: INDUSTRY
- Collaborator: Merck Serono Co., Ltd., China
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Bisoprolol (`cardio:bisoprolol`)
- Registry intervention name matches this record: Atenolol (`cardio:atenolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Merck KGaA, Darmstadt, Germany (`cardio:org-merck-kgaa-darmstadt-germany`)
- Registry lists this organization as a collaborator: Merck Serono Co., Ltd., China (`cardio:org-merck-serono-co-ltd-china`)

## Provenance

Content hash: 5da8f606731d792ba3cb11b593bef82fd8b4209cd8d7710df784831cfc862f9e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
